Browsing: Homepage Slider
The future of individualized medicine: intensified decentralized biotherapeutic production in combination with state-of-the-art diagnostics of the next generation
In this editorial the future of individualized medicine is reviewed, focusing on the decentralization of biotherapeutic production in combination with state-of-the-art diagnostics of the next generation.
In this interview, Nico and Chad (PRA Health Sciences; NC, USA) discuss the advantages, disadvantages and challenges they face with the technologies they utilize, before predicting what the future holds for the field.
Nightingale Health expands biomarker services and Bioanalysis Zone features new article from Bioanalysis
Read time: 1:15 mins
Find out more about this week’s news, with updates from Nightingale Health and a new Bioanalysis article featured on Bioanalysis Zone, about a discussed scientific approach on full and partial validation for general changes in bioanalytical method.
Proposal for risk-based scientific approach on full and partial validation for general changes in bioanalytical method
This manuscript, from Bioanalysis, presents perspectives and recommendations for most conceivable changes that can be made to full and partial validations by members of the discussion groups based on their experiences and discussions at the Japan Bioanalysis Forum Symposium.
In this interview, John Kellie (GSK, PA, USA) discusses the technologies that he uses on a regular basis. He explains how large molecule bioanalysis influences downstream drug development and his future outlook on where the field will be in 5–10 years’ time.
Read time: 1:30 mins
Read more about the top advances in bioanalysis for neurological sciences, including a biomarker for autism and a novel method utilizing a combination of probe electrospray ionization (PESI) and tandem mass spectrometry (MS/MS) for imaging metabolites in a live mouse brain.
In this feature, we investigate the pros and cons of utilizing the different technologies available for large molecule analysis, and consult with experts to answer the key questions involved when choosing a technology for analytical research.
In this conference report we discuss our highlights from the 12th Workshop on Recent Issues in Bioanalysis – Where Regulators and Industry Convene (WRIB; Philadelphia, USA; 9–13 April).